Search
Adial Pharmaceuticals Inc
ADILAdd to Watchlist
4.040USD
-0.160-3.81%
Close 09-22 16:00（ET）
10.42MMarket Cap
LossP/E TTM
Adial Pharmaceuticals Inc (ADIL) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Adial Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
2 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
8.333USD+98.41%
ADIL Analyst Recommendation Trends
In the current month, ADIL has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ADIL average Analyst price target in the last month is 8.333.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
3
3
3
3
3
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
2
3
3
3
3
3
Financial Forecasting
Based on analysts' estimates, ADIL EPS is projected to reach -0.665 in FY2026Q3, following reported EPS of -11.249 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.15
-2.73
-1.03
-0.67
-0.63
Actual
-1.82
-1.48
-11.25
--
--
Surprise
+15.00%
+45.93%
-989.47%
--
--
FAQs
What is Adial Pharmaceuticals Inc's price target?
Analysts forecast that Adial Pharmaceuticals Inc's price target is USD 2.00, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.50.
How have Adial Pharmaceuticals IncADIL's recent earnings per share performed?
The market expectation was USD -11.25, while Adial Pharmaceuticals IncADIL's earnings per share (EPS) for the previous quarter was USD -1.48. EPS for the next quarter is expected at USD -0.67.
What is the analyst rating for Adial Pharmaceuticals Inc?
Based on the ratings of Adial Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.